Okey Stephanie 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Okey Stephanie
Director
Transactions
- Sale
Common Stock
[F1][F2]2026-03-03$39.67/sh−3,000$119,010→ 13,300 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.
- [F2]The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a sale price of $39.67 per share.
Signature
/s/ Tobin Schilke, as attorney-in-fact|2026-03-04